Abstract

Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2022 - Volume 26, Number 2

Page(s): 148

Download in electronic PDF format for $75
  • Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Page 1

Abstract

A formulation for preparing Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • propranolol
  • oral suspension
  • beta blocker
  • antiadrenergic agent
  • sympatholytic agent
  • beta-adrenergic antagonist
  • hypertension
  • high blood pressure

Related Categories

  • FORMULATIONS
  • CARDIOLOGY
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2022
Pg. 148
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2018
Pg. 325
Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 504
Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet
Author(s): Allen Loyd V Jr
Jul/Aug 2014
Pg. 330
Propranolol Hydrochloride 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2022
Pg. 364-368
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Author(s): Riepl Mike
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Nov/Dec 2012
Pg. 513-515
Stability of Propranolol Hydrochloride in SyrSpend SF
Author(s): Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
Sep/Oct 2021
Pg. 414
Clonidine 0.01-mg/mL in Ora-Blend Suspension
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 194-197
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Author(s): Hagan John C III, Everett Eric, Chamberlain Tyler
Nov/Dec 2021
Pg. 503
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 413
Cilazapril 1-mg/mL in Ora-Blend Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2015
Pg. 513
Propranolol Hydrochloride Capsules
Author(s): Allen Loyd V Jr
Jul/Aug 2006
Pg. 304
Propranolol Hydrochloride 1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 496
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions
Author(s): Allen Loyd V Jr
May/Jun 2018
Pg. 233
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2011
Pg. 458-463
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Author(s): Zur Eyal
May/Jun 2006
Pg. 220
Carvedilol 1.25-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 57
Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension
Author(s): Allen Loyd V Jr